General availability on newer Linux distributions and CU1 signal a push toward stability, security and production readiness.

Earlier in December 2025, Recursion Pharmaceuticals reported positive Phase 1b/2 TUPELO trial data for REC-4881 in familial adenomatous polyposis, showing rapid and durable reductions in polyp burden ...

A major outage at internet infrastructure firm Cloudflare knocked parts of the internet offline, disrupting access to X, NJ Transit, ChatGPT and other major platforms ...

Recursion Pharmaceuticals has designated its top research executive, Najat Khan, to succeed co-founder Chris Gibson as president and chief executive of the clinical-stage biotechnology company, ...

Management believes it can drastically cut down the time and cost to bring drugs to market. The company is involved with multiple clinical trials, but none of them are in late stages just yet. Its ...

Managing SQL Server across hybrid and multi-cloud environments has long posed a challenge for database administrators. With data sprawled across on-premises infrastructure, cloud platforms, and edge ...

The once heavily lopsided rivalry between AMD and Intel in pursuit of market share and the revenue that comes with it has become a much more tightly contested battle. Case in point, AMD sent us a ...

We’re excited to announce a new migration capability in Azure Arc to simplify and accelerate SQL Server migration. This new capability, now generally available, is powered by Azure Database Migration ...

Today is Microsoft's July 2025 Patch Tuesday, which includes security updates for 137 flaws, including one publicly disclosed zero-day vulnerability in Microsoft SQL Server. This Patch Tuesday also ...

TL;DR: AMD's server CPU market share surged to 39.4% in Q1 2025, with projections to exceed 40% by year-end and reach 50% in 2026, challenging Intel's dominance. Strong growth in desktop and notebook ...